" " indicates required fields
EVSec’s AI layer provides unparalleled flexibility in adding advanced product security automation, from threat intelligence to risk management and more.
The industry’s first product security solution is leveraging AI to empower automation of the product security lifecycle from threat and vulnerability detection, reporting, and mitigation.
EVSec AutoSynth, a comprehensive, LLM agnostic, AI layer, operates atop EVSec’s robust cyber model, automating the interconnection between the product lifecycle stages and activities that touch development and operations. Leveraging AI, EVSec’s AutoSynth represents a breakthrough in the mobility market, seamlessly integrating advanced automation capabilities into the EVSec product security platform.
C2A Security’s pioneering approach to AI fortifies its DevSecOps platform, enabling swift risk identification and proactive threat management.
AI-powered Product Security
Weeks to months
Hours to minutes
>30 Analysts
1 Analyst
Dozens of Apps and Tools
1 EVSec Platform powered by AI
Manual labor to identify the impact
Automatic enrichment of Lifecycle Risk Management
CRO
C2A Security
VP and GM, Medical Technology
C2A Security
Ken Zalevsky brings over 20 years of medical device cybersecurity experience to his role at C2A Security, where he serves as VP and GM, Medical Technology, following the acquisition of Vigilant Ops in October 2025. A former Bayer executive, Ken founded Vigilant Ops in 2019 after witnessing the consequences of inadequate technical preparation in the healthcare industry. He is an active contributor to CISA’s SBOM working groups and a frequent speaker on software supply chain security. Ken’s mission: transform SBOM from a compliance checkbox into operational intelligence that keeps patients safe while streamlining regulatory processes.